Am Pharma Is A Biopharmaceutical Company Based In The Netherlandsestablished In 2001The Company Specializes In Developing Innovative Therapies For Severe Medical Conditionsparticularly Acute Kidney Injuryakiand Renal Damage Associated With Cardiac Surgeryam Pharma Is Dedicated To Addressing Significant Unmet Medical Needs Through The Preclinical And Clinical Development Of Recombinant Proteinsaiming To Improve Patient Outcomes In Critical Care Environments The Company S Lead Candidateilofotase Alfais A Recombinant Human Alkaline Phosphatase Therapy Currently In Phase 2 Trialsthis Therapy Is Designed To Prevent Or Mitigate Acute Kidney Injuryparticularly In Hospitalized Patients Undergoing High Risk Proceduresam Pharma Emphasizes A Strong Research And Development Focussupported By Strategic Partnershipsincluding A Collaboration With Pfizer To Advance Drug Development And Commercializationthe Company Is Positioned As A Key Innovator In The Nephrology And Critical Care Sectorsworking Towards Delivering The First Approved Therapy For Aki
